Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5974049 | 0.87 | ATM (0.56) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL2890674 | 0.87 | ATM (0.56) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL403340 | 0.87 | ATM (0.56) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL6515050 | 0.85 | HCAR2 (0.46) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL6521081 | 0.84 | ATM (0.45) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL14000214 | 0.83 | ATM (0.48) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL6519152 | 0.82 | ATM (0.44) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL6523098 | 0.82 | ATM (0.42) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL5182457 | 0.81 | TSHR (0.52) | ATMHCAR2SMN1; SMN2TSHRKEAP1 | |
| SCHEMBL2627702 | 0.81 | HCAR2 (0.59) | ATMHCAR2SMN1; SMN2KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ATM 4559/4885HCAR2 3143/4885SMN1; SMN2 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.